BioClinica™, Inc., a global provider of clinical trial management services, has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
“We are proud to partner with Health Sciences International and PRL Central Laboratory Services, expanding upon the dozens of CRO partnerships held by BioClinica worldwide,” said Mark Weinstein, CEO of BioClinica, Inc. “Our newest partners demonstrate the quality and continued growth of the BioClinica Certified Partner Program. To date our certified partners represent a collective experience of more than 700 trials in more than 6,000 sites across 52 countries. This program is one more way that BioClinica provides best-in-class resources for customers.”
Connecticut-based Health Sciences International, Inc. focuses on conducting quality phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal medicine. The organization has participated in more than 100 clinical trials, offering clients consulting services that include R&D expertise, statistical analysis plan development, project and data management, quality enforcement and team building.
PRL Central Laboratory Services specializes in comprehensive diagnostic testing, focusing on protocol requirements. For more than 30 years, the Kansas-based research organization has worked with clinical service providers like BioClinica, ensuring timely results and validated data management for customers.